Factor V Leiden: the venous thrombotic risk in thrombophilic families
Open Access
- 1 September 2000
- journal article
- research article
- Published by Wiley in British Journal of Haematology
- Vol. 110 (4) , 939-945
- https://doi.org/10.1046/j.1365-2141.2000.02236.x
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Long-term outcomes after deep venous thrombosis of the lower extremitiesVascular Medicine, 1998
- Mutant factor V (Arg506Gln) in healthy centenariansThe Lancet, 1996
- Identification of the same factor V gene mutation in 47 out of 50 thrombosis-prone families with inherited resistance to activated protein C.Journal of Clinical Investigation, 1994
- Association of idiopathic venous thromboembolism with single point-mutation at Arg506 of factor VThe Lancet, 1994
- Activated protein C resistance caused by Arg506Gln mutation in factor VaThe Lancet, 1994
- Mutation in blood coagulation factor V associated with resistance to activated protein CNature, 1994
- Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia StudyThe Lancet, 1993
- A prospective study of the incidence of deep‐vein thrombosis within a defined urban populationJournal of Internal Medicine, 1992
- Mortality in hereditary antithrombin-III deficiency—1830 to 1989The Lancet, 1991
- Epidemiology and pathogenesis of venous thrombosisJournal of the American College of Cardiology, 1986